Jakob Knudsen
Vorstandsvorsitzender bei VIROGATES A/S
Vermögen: 116 241 $ am 30.04.2024
Aktive Positionen von Jakob Knudsen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Direktor/Vorstandsmitglied | 01.04.2017 | - |
| Independent Dir/Board Member | 01.04.2017 | - | |
| VIROGATES A/S | Vorstandsvorsitzender | 01.04.2011 | - |
| Investor Relations Kontakt | - | - | |
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Direktor/Vorstandsmitglied | - | - |
| Independent Dir/Board Member | - | - | |
| P.V. Fonden | Direktor/Vorstandsmitglied | - | - |
| Ingeniørsystem A/S | Direktor/Vorstandsmitglied | - | - |
| Jakob Knudsen Enkeltmandsvirksomhed | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Jakob Knudsen
Ehemalige bekannte Positionen von Jakob Knudsen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Finanzdirektor/CFO | 01.02.2008 | 01.04.2011 |
| ALK-ABELLÓ A/S | Corporate Officer/Principal | 01.09.1999 | 01.02.2008 |
Ausbildung von Jakob Knudsen
| Imperial College London | Masters Business Admin |
| University of Copenhagen | Graduate Degree |
Statistik
International
| Dänemark | 9 |
| Vereinigtes Königreich | 3 |
Operativ
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Director of Finance/CFO | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ALK-ABELLÓ A/S | Health Technology |
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| VIROGATES A/S | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
| P.V. Fonden | |
| Ingeniørsystem A/S | |
| Jakob Knudsen Enkeltmandsvirksomhed |
- Börse
- Insiders
- Jakob Knudsen
- Erfahrung
